Interestingly, the pattern of response to specific kinase inhibitors differed between RL and CLL cells as, in contrast to CLL cells, AKT pathway inhibitors completely reversed anti-IgM-induced PDCD4 downregulation and U0126 had no effect in RL cells. Here, PDCD4 is linked to B-cell chronic lymphocytic leukemia.